Can UnitedHealth Group Stock Be An Inflation Hedge?
MarketBeat.com | Mar 29, 2022 05:21AM ET
Health insurance giant UnitedHealth Group (NYSE:UNH) stock has been on a gravity-defying uptrend reaching all-time highs again in 2022 just as inflation hits a 40-year high at 7.5%. The company continues to grow its top and bottom lines, powered by the surge in Medicare Advantage consumers and pandemic-related care.
The repeal of the health insurance tax, along with productivity advances and business mix, helped drop its full-year 2021 operating cost ratio from 16.2% to 14.8%. The company is wildly profitable and has proven that the Medicare Advantage model can work for insurers. Its mission to use improving technology in connecting the fragmented pieces of the healthcare industry appears to be playing out.
However, their $8 billion acquisition of Change Healthcare (NASDAQ:CHNG) is being blocked by the Department of Justice set for trial on Aug. 1, 2022. Prudent investors looking for exposure to a top health insurer can watch for opportunistic pullbacks in shares of UnitedHealth Group.
h2 Q4 Fiscal 2021 Earnings Release /h2On Jan. 19, 2022, UnitedHealth reported its fiscal Q4 2021 earnings report for quarter ended December 2021. The company reported an earnings-per-share (EPS) profit of $4.48 excluding non-recurring items versus consensus analyst estimates for a profit of $4.31, a $0.17 beat.
Revenues grew 12.6% year-over-year (YoY) to $73.74 billion, beating analyst estimates for $72.86 billion. For full-year 2021, the medical care ratio rose to 82.6% versus 79.1% due to COVID-19 and the repeal of the health insurance tax. Days claims payable improved to 46.8 days versus 47.8 days in Q4 2020.
UnitedHealth Group CEO Andrew Witty commented, “Our strong 2021 performance and confident growth outlook for 2022 and beyond reflect the accelerating innovation and expanding capabilities across Optum and UnitedHealthcare.”
h2 Reaffirms Guidance /h2UnitedHealth reaffirmed its full-year fiscal 2022 EPS of $21.10 to $21.60 versus $21.65 consensus analyst estimates. The company expects revenues to come in between $317 billion to $320 billion versus $317.55 billion.
h2 Conference Call Takeaways/h2CEO Witty covered the two key areas driving growth for the company, accelerating patients' transition to Optum value-based care and growing UnitedHealth’s footprint serving Medicare Advantage customers. This should help drive 13% to 16% annual EPS growth rates.
Leveraging technology to optimize physician and hospital capabilities was key in adding an extra $30 billion in annual revenues in 2021. This momentum should continue as the company sees even more opportunities to bring together the fragmented pieces of the healthcare system.
He covered the five key areas of growth. Healthcare delivery growth, behavioral, ambulatory, and virtual care capabilities. Improving the quality of healthcare benefits. Thirdly, to improve technology to provide tailored solutions to more system partners better.
Get The News You Want
Fourth, to vastly improve healthcare financial services like streamlining and simplifying claims payments for providers, payors, payees, and patients while reducing frictions. Lastly, pharmacy services,
h2 Change Healthcare Buyout Block/h2“…Where people interact most often with the health care system. We can better use the significant breadth, volume and value of our foundational pharmacy services and data capabilities and integrate our medical pharmacy and behavioral capabilities.”
On Feb. 24, 2022, the Department of Justice and Attorney Generals in New York and Minnesota filed a civil lawsuit to block United Healthcare’s acquisition of Change Healthcare. They believe this $8 billion acquisition would harm the competition in the health insurance marketplace in addition to the market for vital technology used by health insurers to reduce health care costs and process insurance claims.
The trial is set for Aug. 1, 2022, and will last for 12 days to end on Aug. 16, 2022. Additionally, Change Healthcare wants more than a 5% reverse fee if the deal falls through, as Change Healthcare was to be acquired for $25.75 per share by United Healthcare. Change Healthcare is also selling its ClaimsXten to alleviate concerns from the DOJ lawsuit.
Using market structure low (MSL) triggered the breakout through $133.50.
The daily rifle chart has a pup breakout, too, with a rising 5-period MA at $508.54 and 15-period MA at $497.34. The daily stochastic is kissing near the 90-band preceding a cross up or down. On the upside is the daily upper BBs at $526.19, and on the downside is the daily 50-period MA at $480.58 and the daily lower BBs at $462.10. Prudent investors shouldn’t chase this one but instead watch for opportunistic pullback levels at the $487.19 fib, $478.79 fib, $465.76 fib, $456.60 fib, $447.39 fib, and the $434.41 fib level. Upside trajectories range from the $543.36 fib to the $601.58 fib level.
Original Post
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.